These findings suggest a pleiotropic effect of mTOR inhibitors in BC, and implementing high-throughput techniques such as mass cytometry and single-cell RNA sequencing could provide more comprehensive data to evaluate the effect of such inhibitors on the TIM. This evidence concerns the gene MTOR and breast cancer.